A typical output of a metabolomic experiment is a peak table corresponding to the intensity
of measured signals. Peak table processing, an essential procedure in metabolomics, is …

An increasing percentage of people have or are at risk to develop non-alcoholic fatty liver
disease (NAFLD) worldwide. NAFLD comprises different stadia going from isolated steatosis …

The gut microbiota drives individual sensitivity to excess acetaminophen (APAP)-mediated
hepatotoxicity. It has been reported that the bacterium Akkermansia muciniphila protects …

Background Pediococcus pentosaceus, a promising strain of lactic acid bacteria (LAB), is
gradually attracting attention, leading to a rapid increase in experimental research. Due to …

Akkermansia muciniphila, as a member of the gut microbiota, has been proposed as a next-
generation probiotic. Liver fibrosis is the main determinant of liver dysfunction and mortality …

Background Although microbioa‐based therapies have shown putative effects on the
treatment of non‐alcoholic fatty liver disease (NAFLD), it is not clear how microbiota‐derived …

Biological processes (like microbial growth & physiological response) are usually dynamic
and require the monitoring of metabolic variation at different time-points. Moreover, there is …

Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver disorders
in humans, partly because it is closely related to metabolic disorders of the liver with …

Methods The gut microbiome was analyzed via next-generation sequencing in healthy
people (n= 37) and NAFLD patients with elevated liver enzymes (n= 57). Six-week-old male …

Liver cirrhosis is one of the most prevalent chronic liver diseases worldwide. In addition to
viral hepatitis, diseases such as steatohepatitis, autoimmune hepatitis, sclerosing …